Arkolith/Insider Trading/ORIC/Form 4

Chacko Jacob

PRESIDENT AND CEO, DirectorOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Dec 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$204K
Net Open-Market Flow
-$204K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Sell(S)25K$8.28$204K779K
Dec 15, 2024Option exercise(M)67K—$0803K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2024Option exercise(M)17K—$00
Dec 15, 2024Option exercise(M)28K—$057K
Dec 15, 2024Option exercise(M)22K—$022K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-029631) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML